Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy

Cytokine-induced killer (CIK) cells are demonstrated to possess potent cytolytic effect against ovarian cancer cells in vitro and in vivo. However, the clinical efficacy of maintenance therapy of CIK cells in patients with epithelial ovarian cancer (EOC) after first-line treatment remains unclear. T...

Full description

Bibliographic Details
Main Authors: Yun Zhou, Chang-long Chen, Sen-wei Jiang, Yanling Feng, Linjing Yuan, Ping Chen, Lan Zhang, Shuting Huang, Jundong Li, Jian-Chuan Xia, Min Zheng
Format: Article
Language:English
Published: Taylor & Francis Group 2019-02-01
Series:OncoImmunology
Subjects:
adjuvant cellular immunotherapy
clinical outcome
epithelial ovarian cancer
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1528411

Internet

http://dx.doi.org/10.1080/2162402X.2018.1528411

Similar Items